Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23
Phase 34
Phase 41

Trial Status

Terminated4
Other4

Role Distribution

Principal Investigator2
Other Roles6
PI Rate25%

Activity Timeline

Clinical Trials (8)

NCT01568242Not ApplicableWithdrawn
Changes in Vitreous Temperature During Phacoemulsification
Proliferative Diabetic Retinopathy
StudychairStart date: 2012-02-01
NCT00403702Phase 2/3Withdrawn
Comparison High-density Silicone Oils in Retinal Detachment
Retinal Detachment
StudydirectorStart date: 2006-08-01
NCT00347399Phase 2Terminated
Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration
Age Related Macular Degeneration
StudydirectorStart date: 2006-03-01
NCT00407108Phase 3Withdrawn
Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy
Diabetic Retinopathy
PrincipalinvestigatorStart date: 2006-03-01
NCT00599820Phase 3Terminated
Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks
Angioid StreaksChoroidal Neovascularization
StudydirectorStart date: 2005-11-01
NCT00347165Phase 2Terminated
Intravitreal Bevacizumab for Age-Related Macular Degeneration
Age Related Macular Degeneration
StudychairStart date: 2005-09-01
NCT00417716Phase 3Withdrawn
Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema
Diabetes Mellitus Type 2Diabetic Macular Edema
StudydirectorStart date: 2005-09-01
NCT00500396Phase 4Terminated
Vascular Endothelial Growth Factor in Stage V ROP
Retinopathy of Prematurity
Principalinvestigator

Research Network

Collaboration Network

13 collaborators·36 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Adriana Solís-Vivanco, MD

Asociación para Evitar la Ceguera en México

Moderately Similar
2 trials

Shared therapeutic areas:

Angioid StreaksChoroidal NeovascularizationDiabetes Mellitus, Type 2+1 more

Worked with same sponsors:

Asociación para Evitar la Ceguera en México
Collaborated on 2 trials
Similarity Score48%

Griselda Alvarez-Rivera, MD

Asociación para Evitar la Ceguera en México

Moderately Similar
2 trials

Shared therapeutic areas:

Angioid StreaksChoroidal NeovascularizationDiabetes Mellitus, Type 2+1 more

Worked with same sponsors:

Asociación para Evitar la Ceguera en México
Collaborated on 2 trials
Similarity Score48%

Myriam Hernández-Rojas, MD

Asociación para Evitar la Ceguera en México

Moderately Similar
2 trials

Shared therapeutic areas:

Angioid StreaksChoroidal NeovascularizationDiabetes Mellitus, Type 2+1 more

Worked with same sponsors:

Asociación para Evitar la Ceguera en México
Collaborated on 2 trials
Similarity Score48%

Jans Fromow-Guerra, MD PhD

Asociación para Evitar la Ceguera en México

Moderately Similar
2 trials

Shared therapeutic areas:

Angioid StreaksChoroidal NeovascularizationDiabetes Mellitus, Type 2+1 more

Worked with same sponsors:

Asociación para Evitar la Ceguera en México
Collaborated on 2 trials
Similarity Score48%

Raul Velez-Montoya, MD

Asociación para Evitar la Ceguera en Mexico

Moderately Similar
4 trials

Shared therapeutic areas:

Retinopathy of PrematurityDiabetic Macular EdemaDiabetic Retinopathy

Worked with same sponsors:

Asociación para Evitar la Ceguera en México
Collaborated on 1 trial
Similarity Score34%

Juan M Jiménez-Sierra, MD

Asociación para Evitar la Ceguera en México

Related
1 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Diabetic Macular Edema

Worked with same sponsors:

Asociación para Evitar la Ceguera en México
Collaborated on 1 trial
Similarity Score24%

Elizabeth Reyna-Castelán

Asociación para Evitar la Ceguera en México

Related
1 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Diabetic Macular Edema

Worked with same sponsors:

Asociación para Evitar la Ceguera en México
Collaborated on 1 trial
Similarity Score24%

Elizabeth Reyna-Castelán, MD

Asociación para Evitar la Ceguera en México

Related
1 trials

Shared therapeutic areas:

Angioid StreaksChoroidal Neovascularization

Worked with same sponsors:

Asociación para Evitar la Ceguera en México
Collaborated on 1 trial
Similarity Score24%

Mariana Martínez-Castellanos, MD

Asociación para Evitar la Ceguera en México

Related
1 trials

Shared therapeutic areas:

Angioid StreaksChoroidal Neovascularization

Worked with same sponsors:

Asociación para Evitar la Ceguera en México
Collaborated on 1 trial
Similarity Score24%

Jose Dalma Weizhaus, MD

Asociación para Evitar la Ceguera en México

Related
1 trials

Shared therapeutic areas:

Age-Related Macular Degeneration

Worked with same sponsors:

Asociación para Evitar la Ceguera en México
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (8)

Showing 8 of 8 trials

NCT01568242Not ApplicableStudyChair

Changes in Vitreous Temperature During Phacoemulsification

Proliferative Diabetic Retinopathy
Withdrawn
NCT00403702Phase 2/3StudyDirector

Comparison High-density Silicone Oils in Retinal Detachment

Retinal Detachment
Withdrawn
NCT00347399Phase 2StudyDirector

Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration

Age Related Macular Degeneration
Terminated
NCT00407108Phase 3PrincipalInvestigator

Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy

Diabetic Retinopathy
Withdrawn
NCT00599820Phase 3StudyDirector

Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks

Angioid StreaksChoroidal Neovascularization
Terminated
NCT00347165Phase 2StudyChair

Intravitreal Bevacizumab for Age-Related Macular Degeneration

Age Related Macular Degeneration
Terminated
NCT00417716Phase 3StudyDirector

Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema

Diabetes Mellitus Type 2Diabetic Macular Edema
Withdrawn
NCT00500396Phase 4PrincipalInvestigator

Vascular Endothelial Growth Factor in Stage V ROP

Retinopathy of Prematurity
Terminated

All 8 trials loaded